These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 29453736)

  • 1. Reproductive epidemiology of glial tumors may reveal novel treatments: high-dose progestins or progesterone antagonists as endocrino-immune modifiers against glioma.
    Altinoz MA; Ozpinar A; Elmaci I
    Neurosurg Rev; 2019 Jun; 42(2):351-369. PubMed ID: 29453736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progesterone receptor antagonism inhibits progestogen-related carcinogenesis and suppresses tumor cell proliferation.
    Lee O; Choi MR; Christov K; Ivancic D; Khan SA
    Cancer Lett; 2016 Jul; 376(2):310-7. PubMed ID: 27080304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From epidemiology and neurodevelopment to antineoplasticity. Medroxyprogesterone reduces human glial tumor growth in vitro and C6 glioma in rat brain in vivo.
    Altinoz MA; Nalbantoglu J; Ozpinar A; Emin Ozcan M; Del Maestro RF; Elmaci I
    Clin Neurol Neurosurg; 2018 Oct; 173():20-30. PubMed ID: 30055402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meningioma and hormonal influences.
    Wahab M; Al-Azzawi F
    Climacteric; 2003 Dec; 6(4):285-92. PubMed ID: 15006250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progesterone Receptor Isoform Ratio: A Breast Cancer Prognostic and Predictive Factor for Antiprogestin Responsiveness.
    Rojas PA; May M; Sequeira GR; Elia A; Alvarez M; Martínez P; Gonzalez P; Hewitt S; He X; Perou CM; Molinolo A; Gibbons L; Abba MC; Gass H; Lanari C
    J Natl Cancer Inst; 2017 Jul; 109(7):. PubMed ID: 28376177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor effects of antiprogesterones on human meningioma cells in vitro and in vivo.
    Matsuda Y; Kawamoto K; Kiya K; Kurisu K; Sugiyama K; Uozumi T
    J Neurosurg; 1994 Mar; 80(3):527-34. PubMed ID: 8113866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mifepristone: antineoplastic studies.
    Sartor O; Figg WD
    Clin Obstet Gynecol; 1996 Jun; 39(2):498-505. PubMed ID: 8734014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Applicability of selective progesterone receptor modulators in the treatment of uterine leiomyomata and their future role in the field of gynecology].
    Brazert M; Korman MP; Pawelczyk LA
    Ginekol Pol; 2013 Sep; 84(9):794-800. PubMed ID: 24191519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocrine manipulation of meningiomas with medroxyprogesterone acetate. Effect of MPA on receptor status of meningioma cytosols.
    Markwalder TM; Waelti E; König MP
    Surg Neurol; 1987 Jul; 28(1):3-9. PubMed ID: 2954242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dienogest, a novel synthetic steroid, overcomes hormone-dependent cancer in a different manner than progestins.
    Katsuki Y; Shibutani Y; Aoki D; Nozawa S
    Cancer; 1997 Jan; 79(1):169-76. PubMed ID: 8988742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progesterone receptor modulators for endometriosis.
    Fu J; Song H; Zhou M; Zhu H; Wang Y; Chen H; Huang W
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD009881. PubMed ID: 28742263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormonotherapy of meningiomas with medroxyprogesterone acetate. Immunohistochemical demonstration of the effect of medroxyprogesterone acetate on growth fractions of meningioma cells using the monoclonal antibody Ki-67.
    Markwalder TM; Gerber HA; Waelti E; Schaffner T; Markwalder RV
    Surg Neurol; 1988 Aug; 30(2):97-101. PubMed ID: 2969629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medroxyprogesterone effects on colony growth, autophagy and mitochondria of C6 glioma cells are augmented with tibolone and temozolomide: Cell kinetic and electron microscopical studies with a broad review of the literature.
    Elmaci İ; Ozpinar A; Bilir A; Altinoz MA
    Clin Neurol Neurosurg; 2019 Feb; 177():77-85. PubMed ID: 30622045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective progesterone receptor modulators: new possibilities for gynecologic hormone therapy.
    Sarvilinna N; Unkila-Kallio L; Härkki P; Tiitinen A; Heikinheimo O
    Duodecim; 2017; 133(1):27-33. PubMed ID: 29199806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progesterone receptor involvement in independent tumor growth in MPA-induced murine mammary adenocarcinomas.
    Montecchia MF; Lamb C; Molinolo AA; Luthy IA; Pazos P; Charreau E; Vanzulli S; Lanari C
    J Steroid Biochem Mol Biol; 1999 Jan; 68(1-2):11-21. PubMed ID: 10215033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyproterone, norethindrone, medroxyprogesterone and levonorgestrel are less potent local human growth hormone and insulin-like growth factor I secretion stimulators than progesterone in human breast cancer explants expressing the estrogen receptor.
    Milewicz T; Kolodziejczyk J; Krzysiek J; Basta A; Sztefko K; Kurek S; Stachura J; Gregoraszczuk EL
    Gynecol Endocrinol; 2002 Aug; 16(4):319-29. PubMed ID: 12396561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study on the treatment of high dose mifepristone and progesterone in endometrial carcinoma].
    Li CZ; Wen ZQ; Lan SM; Wang JY; Liu Y
    Zhonghua Fu Chan Ke Za Zhi; 2003 Sep; 38(9):552-5. PubMed ID: 14680611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Next step in the development of mesoprogestins: the preclinical profile of EC313.
    Błaszczak-Świątkiewicz K; Krupa A; Mnich E; Elger W; Oettel M; Nair H; Wierzbicki M; Sieroszewski P; Shaked Z
    Front Endocrinol (Lausanne); 2023; 14():1201547. PubMed ID: 37766684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of progesterone receptor messenger ribonucleic acid by progestin in human endometrial stromal cells.
    Tseng L; Zhu HH
    Biol Reprod; 1997 Dec; 57(6):1360-6. PubMed ID: 9408241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High progesterone receptor concentration in a variant of the ZR-75-1 human breast cancer cell line adapted to growth in oestrogen free conditions.
    van den Berg HW; Martin J; Lynch M
    Br J Cancer; 1990 Apr; 61(4):504-7. PubMed ID: 2139575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.